NAMYANG ISSUES AN APOLOGY
입력 2021.04.16 (15:09)
수정 2021.04.16 (16:46)
읽어주기 기능은 크롬기반의
브라우저에서만 사용하실 수 있습니다.
[Anchor Lead]
Namyang Dairy Products has apologized after its announcement that its yogurt product ‘Bulgaris’ is effective in suppressing COVID-19 drew controversy. In a press release, the company said that a study on the product’s antiviral effects was not in the stage of human clinical trials and apologized for causing public misunderstanding. Namyang Dairy said that during the symposium, it did explain the research results were still in the cell experiment phase, but again reiterated its apology saying the effects cannot be definitive without undergoing clinical trials on humans.
Namyang Dairy Products has apologized after its announcement that its yogurt product ‘Bulgaris’ is effective in suppressing COVID-19 drew controversy. In a press release, the company said that a study on the product’s antiviral effects was not in the stage of human clinical trials and apologized for causing public misunderstanding. Namyang Dairy said that during the symposium, it did explain the research results were still in the cell experiment phase, but again reiterated its apology saying the effects cannot be definitive without undergoing clinical trials on humans.
■ 제보하기
▷ 카카오톡 : 'KBS제보' 검색, 채널 추가
▷ 전화 : 02-781-1234, 4444
▷ 이메일 : kbs1234@kbs.co.kr
▷ 유튜브, 네이버, 카카오에서도 KBS뉴스를 구독해주세요!
- NAMYANG ISSUES AN APOLOGY
-
- 입력 2021-04-16 15:09:01
- 수정2021-04-16 16:46:05
[Anchor Lead]
Namyang Dairy Products has apologized after its announcement that its yogurt product ‘Bulgaris’ is effective in suppressing COVID-19 drew controversy. In a press release, the company said that a study on the product’s antiviral effects was not in the stage of human clinical trials and apologized for causing public misunderstanding. Namyang Dairy said that during the symposium, it did explain the research results were still in the cell experiment phase, but again reiterated its apology saying the effects cannot be definitive without undergoing clinical trials on humans.
Namyang Dairy Products has apologized after its announcement that its yogurt product ‘Bulgaris’ is effective in suppressing COVID-19 drew controversy. In a press release, the company said that a study on the product’s antiviral effects was not in the stage of human clinical trials and apologized for causing public misunderstanding. Namyang Dairy said that during the symposium, it did explain the research results were still in the cell experiment phase, but again reiterated its apology saying the effects cannot be definitive without undergoing clinical trials on humans.
이 기사가 좋으셨다면
-
좋아요
0
-
응원해요
0
-
후속 원해요
0
오늘의 핫 클릭
실시간 뜨거운 관심을 받고 있는 뉴스
헤드라인
많이 본 뉴스
-
각 플랫폼에서 최근 1시간 동안 많이 본 KBS 기사를 제공합니다.
-
각 플랫폼에서 최근 1시간 동안 많이 본 KBS 기사를 제공합니다.
-
각 플랫폼에서 최근 1시간 동안 많이 본 KBS 기사를 제공합니다.
이 기사에 대한 의견을 남겨주세요.